Intravitreal aflibercept for diabetic macular oedema: Moorfields’ real-world 12-month visual acuity and anatomical outcomes

Marko Lukić(Moorfields Eye Hospital NHS Foundation Trust), Ranjan Rajendram(University College London), Zaid Shalchi(Moorfields Eye Hospital NHS Foundation Trust), Robin Hamilton(Moorfields Eye Hospital NHS Foundation Trust), Philip Hykin(Moorfields Eye Hospital), Pearse A. Keane(University College London), Sobha Sivaprasad(Moorfields Eye Hospital), Praveen J. Patel(UK Biobank), Dawn A. Sim(Moorfields Eye Hospital NHS Foundation Trust), Gwyn Samuel Williams(Moorfields Eye Hospital NHS Foundation Trust), Deepthy Menon(Moorfields Eye Hospital NHS Foundation Trust), Alice Bruynseels(Moorfields Eye Hospital NHS Foundation Trust)
European Journal of Ophthalmology
February 26, 2019
10.1177/1120672119833270
Cited by 35

Related Papers

Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes
|JAMA|2017|2.3k
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k
A foundation model for generalizable disease detection from retinal images
|Nature|2023|856
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
|Ophthalmology|2010|510
Deep learning in ophthalmology: The technical and clinical considerations
|Progress in Retinal and Eye Research|2019|509